Arch Therapeutics to Present at The Biotech Showcase(TM) 2017 Conference on January 10th, 2017
FRAMINGHAM, MA--(Marketwired - Jan 5, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5™ devices for use in controlling bleeding and fluid loss in order to provide …